lobbying_activities: 1416223
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1416223 | 2d45c420-5f89-4213-9818-f9d1a1eef06c | Q2 | COVIDIEN LP | 319778 | COVIDIEN LP | 2013 | second_quarter | PHA | Issues involving controlled substances and pain and addiction drugs generally. | Energy, Dept of,Executive Office of the President (EOP),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Office of Science & Technology Policy (OSTP),SENATE,State, Dept of (DOS) | 760000 | 0 | 0 | 2013-07-19T10:38:34.847000-04:00 |